The incidence of lower-extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast-derived dermal substitute

Advances in Skin and Wound Care

Volumn 28, Issue 1, 2015, Pages 17-20

  Frykberg, Robert G ^a   Marston, William A ^b   Cardinal, Matthew ^c  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Novartis Vaccines and Diagnostic   (United States)

Author keywords

Amputation; Chronic wounds; Diabetic foot ulcer; Living skin equivalent

Indexed keywords

BIOCOMPATIBLE COATED MATERIAL; TRANSCYTE;

AMPUTATION; ARTIFICIAL SKIN; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; FIBROBLAST; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; UTILIZATION;

AMPUTATION; COATED MATERIALS, BIOCOMPATIBLE; DIABETIC FOOT; FEMALE; FIBROBLASTS; HUMANS; MALE; RETROSPECTIVE STUDIES; SKIN, ARTIFICIAL;

EID: 84928156847     PISSN: 15277941     EISSN: 15388654     Source Type: Journal    
DOI: 10.1097/01.ASW.0000456630.12766.e9     Document Type: Article

References (16)

1. Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006;45(5 suppl):S1-66.
2. Consensus Development Conference on Diabetic Foot Wound Care: April 7-8, 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 1999;22:1354-60.
3. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7.
4. Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55.
5. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006;14:680-92.
6. Frykberg RG. Diabetic foot ulcers: Pathogenesis and management. Am Fam Physician 2002; 66:1655-62.
7. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288-93.
8. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Derma graft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003;26:1701-5.
9. Dermagraft [directions for use]. San Diego, CA: Shire Regenerative Medicine; 2012.
10. Apligraf [prescribing information]. Canton, MA: Organogenesis; 2010.
11. Veves A, Falanga V, Armstrong DG, Sabolinski ML; Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care 2001;24: 290-5.
12. Morris AD, McAlpine R, Steinke D, et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998;21: 738-43.
13. Muller IS, de Grauw WJ, van Gerwen WH, Bartelink ML, van den Hoogen HJ, Rutten GE. Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diabetes Care 2002;25:570-4.
14. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999;22:1029-35.
15. Moss SE, Klein R, Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999;22:951-9.
16. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003;26:491-4.